NCT04975269View on ClinicalTrials.gov

Acetazolamide Trial in Normal Pressure Hydrocephalus

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 17, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Idiopathic Normal Pressure Hydrocephalus (INPH)
Interventions
DRUG

Acetazolamide

Target dose: 500 mg / day

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

Department of Clinical Neurophysiology, Neurosurgery and Neurology, Uppsala University Hospital, Uppsala

All Listed Sponsors
collaborator

Uppsala University

OTHER

collaborator

Swedish Society for Medical Research

OTHER

lead

Uppsala University Hospital

OTHER